Moreover, in epithelial ovarian cancer (EOC) and human endometrial cancer, its expression is down-regulated, which signifies that fibulin-5 acts as a tumor suppresser for ovarian cancer [127,128,129]. Here, FBLN5 is linked to ovarian carcinoma.